Payer PolicyActive
SURG.00159 Focal Laser Ablation for the Treatment of Prostate Cancer
ANTHEM-SURG.00159
Anthem
Effective: April 16, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses focal laser ablation, a focal therapy that uses laser energy to ablate prostate tissue for prostate cancer. Anthem considers focal laser ablation investigational and not medically necessary; it is not covered for prostate cancer at any stage or risk category. Claims for this service, including those billed under CPT/HCPCS 55899 or S2588, will be denied.
Coverage Criteria Preview
Key requirements from the full policy
"Focal laser ablation is consideredinvestigational and not medically necessaryfor the treatment of prostate cancer."
Sign up to see full coverage criteria, indications, and limitations.